NAFLD has become the most common chronic liver disease in the world, with a global comprehensive prevalence of 25% and an increasing trend year by year [ 1 ].
← all excerpts
Circulating Bone morphogenetic protein 9 (BMP9) as a new biomarker for noninvasive stratification of nonalcoholic fatty liver disease and metabolic syndrome.
1
—
—